Victor E. Reuter
Universidade de São Paulo, Memorial Sloan Kettering Cancer Center
Papers
2
Total Citations
32
H-Index
2
About
Victor E. Reuter is a leading figure in urologic pathology, with a career dedicated to advancing the diagnosis and treatment of prostate cancer. His research centers on the intersection of pathology, surgical oncology, and translational drug development. Dr. Reuter has made seminal contributions to the field by pioneering neoadjuvant clinical trial platforms, such as his work with degarelix prior to prostatectomy for intermediate- and high-risk patients. This framework allows for the rapid evaluation of targeted agents by ensuring robust tumor tissue collection and validated biomarker assays, directly bridging the gap between laboratory discovery and clinical application. His impact is further underscored by his involvement in landmark studies, including a pilot investigation of salvage laparoscopic prostatectomy for recurrent prostate cancer, which provided critical Level 4 evidence for managing post-radiation biochemical recurrence. With over 30 citations on this single case series alone, Dr. Reuter’s work has shaped surgical decision-making and trial design. A master of integrating morphological expertise with clinical innovation, he remains a vital voice in the quest for personalized, evidence-based care in prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2